The oral presentation resumes all goals and obstacles we have met so far in the design of our clinical study involving engineered muscle-derived stem cells for the treatment of Duchenne muscular dystrophy.

Preclinical experience and perspectives of a clinical trial using CD133 stem cells / Y. Torrente. ((Intervento presentato al convegno EMBO tenutosi a Manchester nel 2015.

Preclinical experience and perspectives of a clinical trial using CD133 stem cells

Y. Torrente
Primo
2015

Abstract

The oral presentation resumes all goals and obstacles we have met so far in the design of our clinical study involving engineered muscle-derived stem cells for the treatment of Duchenne muscular dystrophy.
10-set-2015
Settore MED/26 - Neurologia
Preclinical experience and perspectives of a clinical trial using CD133 stem cells / Y. Torrente. ((Intervento presentato al convegno EMBO tenutosi a Manchester nel 2015.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/315939
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact